Given that increased CCL2 and CXCL10 expression has been reported in PD brains and cerebrospinal fluid [51,53], our findings suggest that ATM inhibition may modulate inflammatory signaling pathways to mitigate neuroinflammation. The gene discussed is CXCL10; the disease is Parkinson disease.